BP
ELV icon

BNP Paribas’s Elevance Health ELV Stock Holding History

BNP Paribas’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
476
-240
-34% -$89K 0.01% 213
2026
Q1 		$210K Hold
716
– – 0.01% 220
2025
Q4 		$251K Hold
716
– – 0.01% 232
2025
Q3 		$231K Hold
716
– – 0.01% 214
2025
Q2 		$278K Buy
716
+411
+135% +$165K 0.01% 218
2025
Q1 		$133K Sell
305
-11,163
-97% -$4.48M 0.01% 241
2024
Q4 		$4.23M Sell
11,468
-682
-6% -$285K 0.03% 91
2024
Q3 		$6.32M Sell
12,150
-194
-2% -$104K 0.26% 65
2024
Q2 		$6.69M Sell
12,344
-186
-1% -$98.3K 0.34% 58
2024
Q1 		$6.5M Buy
+12,530
New +$6.23M 0.3% 66

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BNP Paribas's ELV Position: Q2 2026 in Review

BNP Paribas reduced its Elevance Health (ELV) stake by 34% in Q2 2026, selling an estimated $89K and leaving 476 shares worth $184K. The position accounts for 0.01% of the portfolio, ranked #213.

BNP Paribas first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.69M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BNP Paribas held 476 shares of Elevance Health worth $184K as of Q2 2026.
  • BNP Paribas sold 240 Elevance Health shares in Q2 2026, an estimated $89K.
  • Elevance Health made up 0.01% of BNP Paribas's portfolio in Q2 2026, its #213 holding.
  • BNP Paribas first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's Elevance Health position peaked at $6.69M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.